Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Interest Coverage Ratio (2019 - 2022)

Historic Interest Coverage Ratio for Keros Therapeutics (KROS) over the last 4 years, with Q1 2022 value amounting to 24126.0.

  • Keros Therapeutics' Interest Coverage Ratio fell 5299.64% to 24126.0 in Q1 2022 from the same period last year, while for Dec 2022 it was 114790.0, marking a year-over-year decrease of 71450.34%. This contributed to the annual value of 114790.0 for FY2022, which is 71450.34% down from last year.
  • Per Keros Therapeutics' latest filing, its Interest Coverage Ratio stood at 24126.0 for Q1 2022, which was down 5299.64% from 4866.0 recorded in Q4 2021.
  • In the past 5 years, Keros Therapeutics' Interest Coverage Ratio ranged from a high of 775.33 in Q3 2019 and a low of 24126.0 during Q1 2022
  • In the last 4 years, Keros Therapeutics' Interest Coverage Ratio had a median value of 8444.0 in 2020 and averaged 9954.99.
  • As far as peak fluctuations go, Keros Therapeutics' Interest Coverage Ratio crashed by 72338.74% in 2020, and later soared by 6338.88% in 2021.
  • Over the past 4 years, Keros Therapeutics' Interest Coverage Ratio (Quarter) stood at 775.33 in 2019, then tumbled by 1614.23% to 13291.0 in 2020, then soared by 63.39% to 4866.0 in 2021, then plummeted by 395.81% to 24126.0 in 2022.
  • Its Interest Coverage Ratio was 24126.0 in Q1 2022, compared to 4866.0 in Q4 2021 and 20197.0 in Q3 2021.